MediWound Stock (NASDAQ:MDWD)


ForecastChart

Previous Close

$18.07

52W Range

$14.14 - $22.50

50D Avg

$17.74

200D Avg

$18.42

Market Cap

$201.77M

Avg Vol (3M)

$103.51K

Beta

0.28

Div Yield

-

MDWD Company Profile


MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

111

IPO Date

Mar 20, 2014

Website

MDWD Performance


Latest Earnings Call Transcripts


Q2 22Aug 10, 22 | 12:31 AM
Q1 22May 17, 22 | 12:04 PM
Q4 21Mar 17, 22 | 12:31 PM

Peer Comparison


TickerCompany
ASMBAssembly Biosciences, Inc.
GNLXGenelux Corporation
EPRXEupraxia Pharmaceuticals Inc.
SGMOSangamo Therapeutics, Inc.
CRBPCorbus Pharmaceuticals Holdings, Inc.
CDXSCodexis, Inc.
SLSSELLAS Life Sciences Group, Inc.
GNFTGenfit S.A.
TARAProtara Therapeutics, Inc.
TickerGate Footer Logo

Tickergate is an advanced stock research & comparison platform for informed data-driven investment decisions. 100% customizable, institutional-grade data, easy to use.

Company

AboutContact

Connect

LinkedIn

©2025 Tickergate

Tickergate does not provide financial advices and does not issue recommendations or offers to buy stocks of sell any securities. Information is provided 'as-is' and solely for informational purposes as an advice. Tickergate does not bear any responsibility or any losses or damages that may occur as a result of reliance on this data.
Start a conversation

Ask me anything about stocks, markets, or financial data.

Market Trends
Compare Stocks